Contribution of nicotinic acetylcholine receptors containing the β2-subunit to the behavioural effects of nicotine

Biochemical Society Transactions

Volumn 25, Issue 3, 1997, Pages 824-829

  Picciotto, M R ^a   Zoli, M ^b   Zachariou, V ^a   Changeux, J P ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ANABASINE; CYTISINE; EPIBATIDINE; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; AVOIDANCE BEHAVIOR; BEHAVIOR; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; MAZE TEST; MOUSE; MUTANT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REWARD; TRANQUILIZING ACTIVITY;

ANIMALIA;

EID: 0030875893     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/bst0250824     Document Type: Conference Paper

References (50)

1. Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., Le Novère, N., Vincent, P., Merlo-Pich, E., Brulet, P. and Changeux, J.-P. (1995) Nature (London) 374, 65-67
2. Galzi, J.-L., Revah, F., Bessis, A. and Changeux, J.-P. (1991) Annu. Rev. Pharmacol. 31, 37-72
3. Role, L. W. (1992) Curr. Opin. Neurobiol. 2, 254-262
4. Le Novère, N. and Changeux, J.-P. (1995) J. Mol. Evol. 40, 155-172
5. Sargent, P. B. (1993) Annu. Rev. Neurosci. 16, 403-443
6. Hill, Jr., J. A., Zoli, M., Bourgeois, J.-P. and Changeux, J.-P. (1993) J. Neurosci. 13, 1551-1568
7. Zoli, M., Le Novère, N., Hill, J. A. J. and Changeux, J.-P. (1995) J. Neurosci. 15, 1912-1939
8. Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J. and Swanson, L. W. (1989) J. Comp. Neurol. 284, 314-335
9. Halvorsen, S. W. and Berg, D. K. (1990) J. Neurosci. 10, 1711-1718
10. Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B. and Kellar, K. J. (1992) Mol. Pharmacol. 41, 31-37
11. Conroy, W. G., Vernallis, A. B. and Berg, D. K. (1992) Neuron 9, 679-691
12. Le Novère, N., Zoli, M. and Changeux, J.-P. (1996) Eur. J. Neurosci. 8, 2428-2439
13. Pomerleau, O. F. (1986) Psychopharm. Bull. 22, 865-869
14. Gilbert, D. G., Robinson, J. H., Chamberlin, C. L. and Spielberger, C. D. (1989) Psychophysiology 26, 311-319
15. Cao, W., Burkholder, T., Wilkins, L. and Collins, A. C. (1993) Pharmacol. Biochem. Behav. 45, 803-909
16. Brioni, J. D., O'Neill, A. B., Kim, D. J. B. and Decker, M. W. (1993) Eur. J. Pharmacol. 238, 1-8
17. Costall, B., Kelly, M. E., Naylor, R. J. and Onaivi, E. S. (1989) Pharmacol. Biochem. Behav. 33, 197-203
18. Davis, M. (1992) Trends Pharmacol. Sci. 13, 35-41
19. Brioni, J. D., O'Neill, A. B., Kim, D. B., Buckley, M. J., Decker, M. W. and Arneric, S. P. (1994) J. Pharmacol. Exp. Ther. 271, 353-361
20. Arneric, S. P., Sullivan, J. P. and Williams, M. (1995) in Psychopharmacology: The Fourth Generation of Progress (Bloom, F. E. and Kupfer, D. J., eds.), pp. 95-110, Raven Press, New York
21. Tripathi, H. L., Martin, B. R. and Aceto, M. D. (1982) J. Pharmacol. Exp. Ther. 221, 91-96
22. Taguchi, K., Andresen, M. J. and Hentall, I. D. (1991) NeuroReport 2, 789-792
23. Corrigall, W. A. and Coen, K. M. (1989) Psychopharmacology 99, 473-478
24. Risner, M. E. and Goldberg, S. R. (1983) J. Pharmacol. Exp. Ther. 224, 319-326
25. Slifer, B. L. and Balster, R. L. (1985) Pharmacol. Biochem. Behav. 22, 61-69
26. Henningfield, J. E., Miyasato, K. and Jasinski, D. R. (1983) Pharmacol. Biochem. Behav. 19, 887-890
27. Shoaib, M., Stolerman, I. and Kumar, C. (1994) Psychopharmacology 113, 445-452
28. Risinger, F. O. and Oakes, R. A. (1995) Pharmacol. Biochem. Behav. 51, 457-461
29. Clarke, P. B., Fu, D. S., Jakubovic, A. and Fibiger, H. C. (1988) J. Pharmacol. Exp. Ther. 246, 701-708
30. Corrigall, W. A., Franklin, K. B., Coen, K. M. and Clarke, P. B. (1992) Psychopharmacology 107, 285-289
31. Nestler, E. (1992) J. Neurosci. 12, 2439-2450
32. Imperato, A., Mulas, A. and Di Chiara, G. (1986) Eur. J. Pharmacol. 132, 337-338
33. Deneris, E. S., Connolly, J., Rogers, S. and Duvoisin, R. (1991) Trends Pharmacol. Sci. 12, 34-40
34. Wada, K., Dechesne, C., Shimasaki, S., King, R., Kusano, K., Buonanno, A., Hampson, D., Banner, C., Wenthold, R. and Nakatani, Y. (1989) Nature (London) 342, 684-689
35. Wada, E., McKinnon, D., Heinemann, S., Patrick, J. and Swanson, L. W. (1990) Brain Res. 526, 45-53
36. Clarke, P. B. S. and Pert, A. (1985) Brain Res. 348, 355-358
37. Levin, E. D. (1992) Psychopharmacology 108, 417-431
38. Wesnes, K., Warburton, D. M. and Matz, B. (1983) Neuropsychobiology 9, 41-44
39. Wesnes, K. and Warburton, D. M. (1984) Psychopharmacology 82, 147-150
40. Warburton, D. M. (1992) Prog. Neuropsychopharmacol. Biol. Psychiatry 16, 181-199
41. Flicker, C., Dean, R. L., Watkins, D. L., Fisher, S. K. and Bartus, R. T. (1983) Pharmacol. Biochem. Behav. 18, 973-981
42. Levin, E. D., Christopher, N. C., Briggs, S. J. and Rose, J. E. (1993) Cognit. Brain Res. 1, 137-143
43. Muir, J. L., Dunnett, S. B., Robbins, T. W. and Everitt, B. J. (1992) Exp. Brain Res. 89, 611-622
44. McGurk, S. R., Levin, E. D. and Butcher, L. L. (1989) Psychopharmacology 99, 371-373
45. Turchi, J., Holley, L. A. and Sarter, M. (1995) Psychopharmacology 118, 195-205
46. Granon, S., Poucet, B., Thinus-Blanc, C., Changeux, J. P. and Vidal, C. (1995) Psychopharmacology 119, 139-144
47. Nordberg, A. and Bergh, C. (1985) Acta Pharmacol. Toxicol. 56, 337-341
48. Faiman, C. P., de Erausquin, G. A. and Baratti, C. M. (1991) Behav. Neural Biol. 56, 183-199
49. Mifsud, J.-C., Hernandez, L. and Hoebel, B. G. (1989) Brain Res. 478, 365-367
50. Zoli, M., Changeux, J.-P. and Picciotto, M. R. (1996) Soc. Neurosci. Abstr. 22, 1260